Canadian Food Inspection Agency Recalls Two Instant Noodle Products Due to Undeclared Allergen (Peanut)
On July 3, 2024, the Canadian Food Inspection Agency (CFIA) issued a recall notice for two instant noodle products that contained an undeclared allergen (peanut). The details of the recalled products are as follows:
One product is called "Chicken Soup Flavor Instant Noodle" with a net weight of 555g (containing 5 packages, each 111g), with UPC codes 6 935270 34198 8 and 6 935270 641988. The other product is called "Instant Noodles Artificial Pork Bone Soup Flavor" with a net weight of 565g (containing 5 packages, each 113g), with UPC code 6 935270 641971. The recall applies to all packages of these instant noodle products where the peanut ingredient was not properly labeled.

These two affected products have been sold in the provinces of Alberta, British Columbia, and Ontario in Canada. To protect consumer safety and health, the CFIA is strongly advising consumers to refrain from consuming the recalled products. Consumers are urged to check their homes for the affected products, and if found, to immediately stop consumption, discard the product, or return it to the store of purchase.
The CFIA is committed to ensuring food safety and providing a healthy, safe food environment for consumers. They will continue to work diligently to address this issue and safeguard public wellbeing.
2026-09-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Global Countries Impose Tariffs on Chinese Chemical Products
-
Rare Earth and Power: Strategic Probing Beneath the New U.S.–China Trade Framework
-
U.S. Chemical Tariff Deadline Nears as the Industry Faces Cost Repricing and Supply-Chain Adjustment
-
EU Finalizes Anti-Dumping Duties on Chinese Adipic Acid as Chemical Trade Enters a Rule-Intensive Phase
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
China's National Narcotics Control Commission Issues Important Notice: Beware of These 8 Chemicals Being Diverted for Drug Production
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
Supplement Recall Puts Nutrition Ingredient Safety Back Under Pressure
-
Chemours Sells Its Former Titanium Dioxide Site in Taiwan: Turning a “White Powder” Factory into “Wind Power Real Estate” for $360 Million—Buying Not Cash, But Breathing Room
-
The “Counter-Wind Ledger” of CHF 11.2 Billion: Sika Barely Grew in 2025—Yet Kept Taking Market Share
Recommend Reading
-
Kemira to Acquire Water Engineering for USD 150 Million
-
Sumitomo Chemical Launches Pilot Plant for Ethanol-to-Propylene Process
-
U.S.-Iran Détente Triggers Oil Price Plunge, Energy and Chemical Sectors Tumble
-
NextDecade Approves FID for Fourth LNG Train at Rio Grande Project
-
From Coffee Waste to Superfood Additive: EU Declares Pectin-Rich Arabica Extract Safe for Food Use
-
Business Society’s September 8, 2026 Methanol Market Outlook: Volatile Consolidation
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
Business Society’s LLDPE Market Outlook on August 20, 2026: Rising
-
Business Society’s Oil Coke Market Outlook on September 7, 2026: Volatile
-
Mid-September Asphalt Prices Drop in Shandong Region